| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ocular Therapeutix, Inc. (OCUL) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. OCUL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 394.7K | $3.94M | - | |
| Other | 389.3K | $3.88M | - | |
| Other | 330.7K | $3.30M | - | |
| Other | 326.3K | $3.25M | - | |
| Other | 323.4K | $3.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 3,024 | $7.18 | $21,712.32 | -1.1% | +66.2% | +12.7% | |
| May 23, 2025 | Dugel Pravin | See Remarks | Sell | 21,219 | $7.18 | $152,352.42 | -0.6% | +66.2% | +12.7% | |
| May 8, 2025 | Lindstrom Richard L Md65 | Director | Buy | 10,000 | $6.96 | $69,600.00 | +6.1% | +67.8% | - | |
| Feb 24, 2025 | Dugel Pravin | See Remarks | Sell | 21,475 | $6.87 | $147,533.25 | -0.6% | +3.3% | +33.3% | |
| Feb 24, 2025 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 3,061 | $6.87 | $21,029.07 | -1.1% | +3.3% | +33.3% | |
| Feb 24, 2025 | Kaiser Peter | Chief Development Officer | Sell | 3,009 | $6.87 | $20,671.83 | -1.4% | +3.3% | +33.3% | |
| Feb 24, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,895 | $6.84 | $12,961.80 | -0.7% | +3.3% | +33.3% | |
| Feb 4, 2025 | Notman Donald | See Remarks | Sell | 17,420 | $7.82 | $136,239.23 | -4.2% | -1.2% | +9.3% | |
| Nov 25, 2024 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 2,948 | $9.01 | $26,561.48 | -1.1% | -26.1% | +33.4% | |
| Nov 25, 2024 | Kaiser Peter | Chief Development Officer | Sell | 2,897 | $9.01 | $26,101.97 | -1.3% | -26.1% | +33.4% |